PML nuclear bodies and their spatial relationships in the mammalian cell nucleus

Frontiers in Bioscience

Volumn 14, Issue 3, 2009, Pages 1182-1196

  Batty, Elizabeth ^a   Jensen, Kirsten ^a   Freemont, Paul ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Centromeres; Chromatin; Co localization; DNA damage; DNA replication; Immunofluorescence; Interferon; Mammalian nucleus; MHC; Nuclear architecture; Nuclear compartments; Nuclear organization; Nucleoli; PML; PML nuclear bodies; PML nuclear body function; Proteolysis; Review; Spatial associations; Spatial organization; Spatial relationships; Stress; Telomeres; Transcription; Viral response

Indexed keywords

MAMMALIA;

NUCLEAR PROTEIN; PML PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

CELL NUCLEUS; HUMAN; METABOLISM; REVIEW;

CELL NUCLEUS; HUMANS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 63849135038     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3302     Document Type: Article

References (105)

1. Dellaire, G., R. W. Ching, H. Dehghani, Y. Ren & D. P. Bazett-Jones: The number of PML nuclear bodies increases in early S phase by a fission mechanism. J Cell Sci, 119, 1026-33 (2006).
2. Wang, Z. G., L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld & P. P. Pandolfi: Role of PML in cell growth and the retinoic acid pathway. Science, 279, 1547-51 (1998). (Pubitemid 28217080)
3. Zhong, S., S. Muller, S. Ronchetti, P. S. Freemont, A. Dejean & P. P. Pandolfi: Role of SUMO-1-modified PML in nuclear body formation. Blood, 95, 2748-52 (2000).
4. Jensen, K., C. Shiels & P. S. Freemont: PML protein isoforms and the RBCC/TRIM motif. Oncogene, 20, 7223- 33 (2001). (Pubitemid 33105011)
5. Condemine, W., Y. Takahashi, J. Zhu, F. Puvion-Dutilleul, S. Guegan, A. Janin & H. de The: Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res, 66, 6192-8 (2006).
6. Salomoni, P. & C. Bellodi: New insights into the cytoplasmic function of PML. Histol Histopathol, 22, 937- 46 (2007). (Pubitemid 47034159)
7. Kamitani, T., K. Kito, H. P. Nguyen, H. Wada, T. Fukuda-Kamitani & E. T. Yeh: Identification of three major sentrinization sites in PML. J Biol Chem, 273, 26675-82 (1998). (Pubitemid 28471682)
8. Duprez, E., A. J. Saurin, J. M. Desterro, V. Lallemand-Breitenbach, K. Howe, M. N. Boddy, E. Solomon, H. de The, R. T. Hay & P. S. Freemont: SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci, 112 ( Pt 3), 381-93 (1999). (Pubitemid 29080660)
9. Shen, T. H., H. K. Lin, P. P. Scaglioni, T. M. Yung & P. P. Pandolfi: The mechanisms of PML-nuclear body formation. Mol Cell, 24, 331-9 (2006). (Pubitemid 44647906)
10. Bernardi, R. & P. P. Pandolfi: Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol, 8, 1006-16 (2007). (Pubitemid 350174636)
11. Muller, S., M. J. Matunis & A. Dejean: Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. Embo J, 17, 61-70 (1998). (Pubitemid 28041048)
12. Lallemand-Breitenbach, V., J. Zhu, F. Puvion, M. Koken, N. Honore, A. Doubeikovsky, E. Duprez, P. P. Pandolfi, E. Puvion, P. Freemont & H. de The: Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med, 193, 1361-71 (2001). (Pubitemid 32565965)
13. LaMorte, V. J., J. A. Dyck, R. L. Ochs & R. M. Evans: Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci U S A, 95, 4991-6 (1998).
14. Ishov, A. M., A. G. Sotnikov, D. Negorev, O. V. Vladimirova, N. Neff, T. Kamitani, E. T. Yeh, J. F. Strauss 3rd & G. G. Maul: PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol, 147, 221-34 (1999).
15. Sternsdorf, T., K. Jensen & H. Will: Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol, 139, 1621-34 (1997). (Pubitemid 28079228)
16. Dyck, J. A., G. G. Maul, W. H. Miller Jr., J. D. Chen, A. Kakizuka & R. M. Evans: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell, 76, 333-43 (1994). (Pubitemid 24046695)
17. Koken, M. H., F. Puvion-Dutilleul, M. C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne & et al.: The t (15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. Embo J, 13, 1073-83 (1994). (Pubitemid 24074714)
18. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond & A. Dejean: Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell, 76, 345-56 (1994). (Pubitemid 24046696)
19. de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos & A. Dejean: The PML-RAR alpha fusion mRNA generated by the t (15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675-84 (1991). (Pubitemid 121001703)
20. Kakizuka, A., W. H. Miller Jr., K. Umesono, R. P. Warrell Jr., S. R. Frankel, V. V. Murty, E. Dmitrovsky & R. M. Evans: Chromosomal translocation t (15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell, 66, 663-74 (1991). (Pubitemid 121001702)
21. Pandolfi, P. P., F. Grignani, M. Alcalay, A. Mencarelli, A. Biondi, F. LoCoco, F. Grignani & P. G. Pelicci: Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene, 6, 1285-92 (1991). (Pubitemid 21924220)
22. Goddard, A. D., J. Borrow, P. S. Freemont & E. Solomon: Characterization of a zinc finger gene disrupted by the t (15;17) in acute promyelocytic leukemia. Science, 254, 1371-4 (1991). (Pubitemid 21917471)
23. Borden, K. L.: Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol, 22, 5259-69 (2002). (Pubitemid 34755740)
24. Salomoni, P. & P. P. Pandolfi: The role of PML in tumor suppression. Cell, 108, 165-70 (2002). (Pubitemid 34161137)
25. Takahashi, Y., V. Lallemand-Breitenbach, J. Zhu & H. de The: PML nuclear bodies and apoptosis. Oncogene, 23, 2819- 24 (2004). (Pubitemid 38659528)
26. Dellaire, G. & D. P. Bazett-Jones: PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays, 26, 963-77 (2004). (Pubitemid 39273070)
27. Zhong, S., P. Salomoni & P. P. Pandolfi: The transcriptional role of PML and the nuclear body. Nat Cell Biol, 2, E85-90 (2000).
28. Everett, R. D. & M. K. Chelbi-Alix: PML and PML nuclear bodies: implications in antiviral defence. Biochimie, 89, 819-30 (2007). (Pubitemid 47008945)
29. Negorev, D. & G. G. Maul: Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene, 20, 7234- 42 (2001). (Pubitemid 33105012)
30. Parada, L. A., S. Sotiriou & T. Misteli: Spatial genome organization. Exp Cell Res, 296, 64-70 (2004). (Pubitemid 38543214)
31. Misteli, T.: The concept of self-organization in cellular architecture. J Cell Biol, 155, 181-5 (2001). (Pubitemid 34289292)
32. Dundr, M. & T. Misteli: Functional architecture in the cell nucleus. Biochem J, 356, 297-310 (2001). (Pubitemid 32532339)
33. Hancock, R.: Internal organisation of the nucleus: assembly of compartments by macromolecular crowding and the nuclear matrix model. Biol Cell, 96, 595-601 (2004). (Pubitemid 39562234)
34. McManus, K. J. & M. J. Hendzel: CBP, a transcriptional coactivator and acetyltransferase. Biochem Cell Biol, 79, 253-66 (2001). (Pubitemid 32751918)
35. Szostecki, C., H. H. Guldner, H. J. Netter & H. Will: Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol, 145, 4338-47 (1990).
36. Boddy, M. N., K. Howe, L. D. Etkin, E. Solomon & P. S. Freemont: PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene, 13, 971-82 (1996). (Pubitemid 26329084)
37. Boisvert, F. M., M. J. Kruhlak, A. K. Box, M. J. Hendzel & D. P. Bazett-Jones: The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol, 152, 1099-106 (2001). (Pubitemid 34286084)
38. Li,H., C. Leo, J. Zhu, X. Wu, J. O'Neil, E. J. Park & J. D. Chen: Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol, 20, 1784- 96 (2000). (Pubitemid 30100196)
39. Fogal, V., M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P. P. Pandolfi, H. Will, C. Schneider & G. Del Sal: Regulation of p53 activity in nuclear bodies by a specific PML isoform. Embo J, 19, 6185-95 (2000).
40. Alcalay, M., L. Tomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Fagioli, L. Szekely, K. Helin & P. G. Pelicci: The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol, 18, 1084-93 (1998). (Pubitemid 28063443)
41. Szostecki, C., H. Krippner, E. Penner & F. A. Bautz: Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol, 68, 108-16 (1987). (Pubitemid 17044783)
42. Everett, R. D., P. Lomonte, T. Sternsdorf, R. van Driel & A. Orr: Cell cycle regulation of PML modification and ND10 composition. J Cell Sci, 112 ( Pt 24), 4581-8 (1999). (Pubitemid 30034807)
43. Sternsdorf, T., K. Jensen, B. Reich & H. Will: The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem, 274, 12555-66 (1999).
44. Seeler, J. S., A. Marchio, D. Sitterlin, C. Transy & A. Dejean: Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A, 95, 7316-21 (1998). (Pubitemid 28293249)
45. Lehming, N., A. Le Saux, J. Schuller & M. Ptashne: Chromatin components as part of a putative transcriptional repressing complex. Proc Natl Acad Sci U S A, 95, 7322-6 (1998). (Pubitemid 28293250)
46. Kumar, P. P., O. Bischof, P. K. Purbey, D. Notani, H. Urlaub, A. Dejean & S. Galande: Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol, 9, 45-56 (2007). (Pubitemid 46024196)
47. Strudwick, S. & K. L. Borden: The emerging roles of translation factor eIF4E in the nucleus. Differentiation, 70, 10-22 (2002). (Pubitemid 38232695)
48. Lazaris-Karatzas, A., K. S. Montine & N. Sonenberg: Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature, 345, 544-7 (1990).
49. Cohen, N., M. Sharma, A. Kentsis, J. M. Perez, S. Strudwick & K. L. Borden: PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. Embo J, 20, 4547-59 (2001). (Pubitemid 32772048)
50. Culjkovic, B., I. Topisirovic, L. Skrabanek, M. Ruiz-Gutierrez & K. L. Borden: eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR. J Cell Biol, 169, 245-56 (2005). (Pubitemid 40656563)
51. Ruthardt, M., A. Orleth, L. Tomassoni, E. Puccetti, D. Riganelli, M. Alcalay, R. Mannucci, I. Nicoletti, F. Grignani, M. Fagioli & P. G. Pelicci: The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies. Oncogene, 16, 1945-53 (1998). (Pubitemid 28200606)
52. Koken, M. H., A. Reid, F. Quignon, M. K. Chelbi-Alix, J. M. Davies, J. H. Kabarowski, J. Zhu, S. Dong, S. Chen, Z. Chen, C. C. Tan, J. Licht, S. Waxman, H. de The & A. Zelent: Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci U S A, 94, 10255-60 (1997).
53. Grande, M. A., I. van der Kraan, B. van Steensel, W. Schul, H. de The, H. T. van der Voort, L. de Jong & R. van Driel: PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J Cell Biochem, 63, 280-91 (1996). (Pubitemid 26371554)
54. Berciano, M. T., M. Novell, N. T. Villagra, I. Casafont, R. Bengoechea, J. F. Val-Bernal & M. Lafarga: Cajal body number and nucleolar size correlate with the cell body mass in human sensory ganglia neurons. J Struct Biol, 158, 410- 20 (2007). (Pubitemid 46764568)
55. Sun, J., H. Xu, S. H. Subramony & M. D. Hebert: Interactions between coilin and PIASy partially link Cajal bodies to PML bodies. J Cell Sci, 118, 4995-5003 (2005). (Pubitemid 41672431)
56. Stuurman, N., A. de Graaf, A. Floore, A. Josso, B. Humbel, L. de Jong & R. van Driel: A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci, 101 ( Pt 4), 773-84 (1992).
57. Kiesslich, A., A. von Mikecz & P. Hemmerich: Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells. J Struct Biol, 140, 167-79 (2002). (Pubitemid 36139858)
58. von Mikecz, A., S. Zhang, M. Montminy, E. M. Tan & P. Hemmerich: CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J Cell Biol, 150, 265-73 (2000). (Pubitemid 30480242)
59. Xie, S. Q. & A. Pombo: Distribution of different phosphorylated forms of RNA polymerase II in relation to Cajal and PML bodies in human cells: an ultrastructural study. Histochem Cell Biol, 125, 21-31 (2006). (Pubitemid 43049969)
60. Boisvert, F. M., M. J. Hendzel & D. P. Bazett-Jones: Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol, 148, 283-92 (2000). (Pubitemid 30078240)
61. Wang, J., C. Shiels, P. Sasieni, P. J. Wu, S. A. Islam, P. S. Freemont & D. Sheer: Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol, 164, 515-26 (2004). (Pubitemid 38233313)
62. Rockel, T. D., D. Stuhlmann & A. von Mikecz: Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J Cell Sci, 118, 5231-42 (2005). (Pubitemid 41819586)
63. von Mikecz, A.: The nuclear ubiquitin-proteasome system. J Cell Sci, 119, 1977-84 (2006).
64. Gilson, E. & V. Geli: How telomeres are replicated. Nat Rev Mol Cell Biol, 8, 825-38 (2007). (Pubitemid 47462137)
65. Blasco, M. A.: Telomere length, stem cells and aging. Nat Chem Biol, 3, 640-9 (2007). (Pubitemid 47417712)
66. Bryan, T. M., A. Englezou, L. Dalla-Pozza, M. A. Dunham & R. R. Reddel: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med, 3, 1271-4 (1997). (Pubitemid 27508830)
67. Dunham, M. A., A. A. Neumann, C. L. Fasching & R. R. Reddel: Telomere maintenance by recombination in human cells. Nat Genet, 26, 447-50 (2000).
68. Yeager, T. R., A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble & R. R. Reddel: Telomerasenegative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res, 59, 4175-9 (1999). (Pubitemid 29418720)
69. Henson, J. D., A. A. Neumann, T. R. Yeager & R. R. Reddel: Alternative lengthening of telomeres in mammalian cells. Oncogene, 21, 598-610 (2002). (Pubitemid 34146260)
70. Potts, P. R. & H. Yu: The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol, 14, 581-90 (2007). (Pubitemid 47037066)
71. Ferguson, B. J., C. L. Dovey, K. Lilley, A. H. Wyllie & T. Rich: Nuclear phospholipase C gamma: punctate distribution and association with the promyelocytic leukemia protein. J Proteome Res, 6, 2027-32 (2007). (Pubitemid 46814524)
72. Bridger, J. M., H. Herrmann, C. Munkel & P. Lichter: Identification of an interchromosomal compartment by polymerization of nuclear-targeted vimentin. J Cell Sci, 111 ( Pt 9), 1241-53 (1998). (Pubitemid 28266479)
73. Lamond, A. I. & D. L. Spector: Nuclear speckles: a model for nuclear organelles. Nat Rev Mol Cell Biol, 4, 605-12 (2003). (Pubitemid 36934962)
74. Ishov, A. M., R. M. Stenberg & G. G. Maul: Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol, 138, 5-16 (1997). (Pubitemid 27337448)
75. Carbone, R., M. Pearson, S. Minucci & P. G. Pelicci: PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene, 21, 1633-40 (2002). (Pubitemid 34259026)
76. Boe, S. O., M. Haave, A. Jul-Larsen, A. Grudic, R. Bjerkvig & P. E. Lonning: Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. J Cell Sci, 119, 3284-95 (2006). (Pubitemid 44405214)
77. Varadaraj, A., C. L. Dovey, L. Laredj, B. Ferguson, C. E. Alexander, N. Lubben, A. H. Wyllie & T. Rich: Evidence for the receipt of DNA damage stimuli by PML nuclear domains. J Pathol, 211, 471-80 (2007). (Pubitemid 46332559)
78. Dellaire, G., R. W. Ching, K. Ahmed, F. Jalali, K. C. Tse, R. G. Bristow & D. P. Bazett-Jones: Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J Cell Biol, 175, 55-66 (2006). (Pubitemid 44537198)
79. Everett, R. D.: Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol, 8, 365-74 (2006). (Pubitemid 43356028)
80. Ishov, A. M. & G. G. Maul: The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol, 134, 815-26 (1996). (Pubitemid 26278209)
81. Maul, G. G., A. M. Ishov & R. D. Everett: Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology, 217, 67-75 (1996). (Pubitemid 26103599)
82. Carvalho, T., J. S. Seeler, K. Ohman, P. Jordan, U. Pettersson, G. Akusjarvi, M. Carmo-Fonseca & A. Dejean: Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol, 131, 45-56 (1995).
83. Doucas, V., A. M. Ishov, A. Romo, H. Juguilon, M. D. Weitzman, R. M. Evans & G. G. Maul: Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev, 10, 196-207 (1996). (Pubitemid 26044607)
84. Bishop, C. L., M. Ramalho, N. Nadkarni, W. May Kong, C. F. Higgins & N. Krauzewicz: Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA. Mol Cell Biol, 26, 2583-94 (2006).
85. Tsukamoto, T., N. Hashiguchi, S. M. Janicki, T. Tumbar, A. S. Belmont & D. L. Spector: Visualization of gene activity in living cells. Nat Cell Biol, 2, 871-8 (2000).
86. Regad, T. & M. K. Chelbi-Alix: Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene, 20, 7274-86 (2001). (Pubitemid 33105016)
87. Lavau, C., A. Marchio, M. Fagioli, J. Jansen, B. Falini, P. Lebon, F. Grosveld, P. P. Pandolfi, P. G. Pelicci & A. Dejean: The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene, 11, 871-6 (1995).
88. Fuchsova, B., P. Novak, J. Kafkova & P. Hozak: Nuclear DNA helicase II is recruited to IFN-alpha activated transcription sites at PML nuclear bodies. J Cell Biol, 158, 463-73 (2002). (Pubitemid 34851705)
89. Fabunmi, R. P., W. C. Wigley, P. J. Thomas & G. N. DeMartino: Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J Cell Sci, 114, 29-36 (2001). (Pubitemid 32118054)
90. Bonilla, W. V., D. D. Pinschewer, P. Klenerman, V. Rousson, M. Gaboli, P. P. Pandolfi, R. M. Zinkernagel, M. S. Salvato & H. Hengartner: Effects of promyelocytic leukemia protein on virus-host balance. J Virol, 76, 3810-8 (2002). (Pubitemid 34250546)
91. Condemine, W., Y. Takahashi, M. Le Bras & H. de The: A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J Cell Sci, 120, 3219-27 (2007). (Pubitemid 350018413)
92. Bernardi, R., P. P. Scaglioni, S. Bergmann, H. F. Horn, K. H. Vousden & P. P. Pandolfi: PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol, 6, 665-72 (2004). (Pubitemid 38960925)
93. Janderova-Rossmeislova, L., Z. Novakova, J. Vlasakova, V. Philimonenko, P. Hozak & Z. Hodny: PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells. J Struct Biol, 159, 56-70 (2007). (Pubitemid 46880553)
94. Everett, R. D., W. C. Earnshaw, A. F. Pluta, T. Sternsdorf, A. M. Ainsztein, M. Carmena, S. Ruchaud, W. L. Hsu & A. Orr: A dynamic connection between centromeres and ND10 proteins. J Cell Sci, 112 ( Pt 20), 3443-54 (1999).
95. Shiels, C., S. A. Islam, R. Vatcheva, P. Sasieni, M. J. Sternberg, P. S. Freemont & D. Sheer: PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci, 114, 3705-16 (2001). (Pubitemid 33041052)
96. Huang, M. E., Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu & Z. Y. Wang: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-72 (1988).
97. Daniel, M. T., M. Koken, O. Romagne, S. Barbey, A. Bazarbachi, M. Stadler, M. C. Guillemin, L. Degos, C. Chomienne & H. de The: PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood, 82, 1858-67 (1993). (Pubitemid 23278777)
98. Luciani, J. J., D. Depetris, Y. Usson, C. Metzler-Guillemain, C. Mignon-Ravix, M. J. Mitchell, A. Megarbane, P. Sarda, H. Sirma, A. Moncla, J. Feunteun & M. G. Mattei: PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J Cell Sci, 119, 2518-31 (2006). (Pubitemid 44070433)
99. M. H. Koken,, G. Linares-Cruz, F. Quignon, A. Viron, M. K. Chelbi-Alix, J. Sobczak-Thepot, L. Juhlin, L. Degos, F. Calvo & H. de The: The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene, 10, 1315-24 (1995).
100. Dellaire, G., C. H. Eskiw, H. Dehghani, R. W. Ching & D. P. Bazett-Jones: Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J Cell Sci, 119, 1034-42 (2006).
101. Gorisch, S. M., M. Wachsmuth, C. Ittrich, C. P. Bacher, K. Rippe & P. Lichter: Nuclear body movement is determined by chromatin accessibility and dynamics. Proc Natl Acad Sci U S A, 101, 13221-6 (2004). (Pubitemid 39209646)
102. Muratani, M., D. Gerlich, S. M. Janicki, M. Gebhard, R. Eils & D. L. Spector: Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat Cell Biol, 4, 106-10 (2002). (Pubitemid 34141475)
103. Eskiw, C. H., G. Dellaire, J. S. Mymryk & D. P. Bazett-Jones: Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J Cell Sci, 116, 4455-66 (2003). (Pubitemid 37369600)
104. Guillot, P. V., S. Q. Xie, M. Hollinshead & A. Pombo: Fixation-induced redistribution of hyperphosphorylated RNA polymerase II in the nucleus of human cells. Exp Cell Res, 295, 460-8 (2004). (Pubitemid 38490499)
105. M. K. Chelbi-Alix,, L. Pelicano, F. Quignon, M. H. Koken, L. Venturini, M. Stadler, J. Pavlovic, L. Degos & H. de The: Induction of the PML protein by interferons in normal and APL cells. Leukemia, 9, 2027-33 (1995). (Pubitemid 26023786)